D-0212-2026 Class II Ongoing

Recalled by Blossom Pharmaceuticals — Bardej, Goa

FDA drug recall D-0212-2026 was initiated by Blossom Pharmaceuticals on Oct 31, 2025 and is designated Class II. Reason for recall: cGMP deviations The recall status is ongoing. Affected quantity: 33000 containers.

Recall details

Product Type
Drugs
Report Date
Dec 10, 2025
Initiation Date
Oct 31, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
33000 containers

Product description

Globe Zinc Oxide Ointment USP Zinc Oxide 20% Skin Protectant, Net Wt. 2 oz (56.7 g), Distributed by: Trifecta Pharmaceuticals USA 101 NE, Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, NDC 69396-086-02.

Reason for recall

cGMP deviations

Distribution pattern

USA Nationwide

Code information

Lot #: A502404, Exp. Date 2/27; A502405, Exp. Date 2/27; AS02502, Exp. Date 2/28.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0212-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0212-2026. Report a data issue: hello@regdatalab.com.